BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morrens M, De Picker L, Kampen JK, Coppens V. Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis. Schizophr Res 2020;223:43-52. [PMID: 32981827 DOI: 10.1016/j.schres.2020.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Suárez Santiago JE, Roldán GR, Picazo O. Ketamine as a pharmacological tool for the preclinical study of memory deficit in schizophrenia. Behav Pharmacol 2022. [PMID: 36094064 DOI: 10.1097/FBP.0000000000000689] [Reference Citation Analysis]
2 Sathyasaikumar KV, Notarangelo FM, Kelly DL, Rowland LM, Hare SM, Chen S, Mo C, Buchanan RW, Schwarcz R. Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid. Pharmaceuticals 2022;15:1003. [DOI: 10.3390/ph15081003] [Reference Citation Analysis]
3 Morrens M, Overloop C, Coppens V, Loots E, Van Den Noortgate M, Vandenameele S, Leboyer M, De Picker L. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis. Mol Psychiatry 2022. [PMID: 35484245 DOI: 10.1038/s41380-022-01582-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Almulla AF, Vasupanrajit A, Tunvirachaisakul C, Al-hakeim HK, Solmi M, Verkerk R, Maes M. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments. Mol Psychiatry. [DOI: 10.1038/s41380-022-01552-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Coppens V, Verkerk R, Morrens M. Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood. Front Pharmacol 2022;13:825948. [PMID: 35250576 DOI: 10.3389/fphar.2022.825948] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Skorobogatov K, De Picker L, Verkerk R, Coppens V, Leboyer M, Müller N, Morrens M. Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders. Front Immunol 2021;12:716980. [PMID: 34630391 DOI: 10.3389/fimmu.2021.716980] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 De Picker LJ. The future of immunopsychiatry: Three milestones to clinical innovation. Brain Behav Immun Health 2021;16:100314. [PMID: 34589805 DOI: 10.1016/j.bbih.2021.100314] [Reference Citation Analysis]
8 Büki A, Kekesi G, Horvath G, Vécsei L. A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia. Int J Mol Sci 2021;22:10016. [PMID: 34576179 DOI: 10.3390/ijms221810016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Okamoto N, Natsuyama T, Igata R, Konishi Y, Tesen H, Ikenouchi A, Yoshimura R. Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study. Front Psychiatry 2021;12:696059. [PMID: 34393855 DOI: 10.3389/fpsyt.2021.696059] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Hebbrecht K, Skorobogatov K, Giltay EJ, Coppens V, De Picker L, Morrens M. Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis. Front Immunol 2021;12:667179. [PMID: 34093561 DOI: 10.3389/fimmu.2021.667179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bartoli F, Cioni RM, Callovini T, Cavaleri D, Crocamo C, Carrà G. The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites. Schizophr Res 2021;232:61-2. [PMID: 34015557 DOI: 10.1016/j.schres.2021.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]